<?xml version="1.0" encoding="utf-8" ?>
<!DOCTYPE article>
<book xmlns="http://docbook.org/ns/docbook" version="5.0" xmlns:xlink="http://www.w3.org/1999/xlink">
  <info>
    <title>Clinical Decision Support (CDS) Content and Health Level 7 (HL7) - Compliant Knowledge
      Artifacts (KNARTs)</title>
    <subtitle>Women's Health: Cervical Cancer Screening Clinical Content White Paper</subtitle>
    <copyright>
      <year>2018</year>
      <holder>B3 Group, Inc.</holder>
    </copyright>
    <legalnotice>
      <title>B3 Group, Inc.</title>
      <para>NOTICE OF GOVERNMENT COPYRIGHT LICENSE AND UNLIMITED RIGHTS LICENSE</para>
      <para>Licensed under the Apache License, Version 2.0 (the "License"); you may not use this
        file except in compliance with the License.</para>
      <para>You may obtain a copy of the License at <link
          xlink:href="http://www.apache.org/licenses/LICENSE-2.0"
          >http://www.apache.org/licenses/LICENSE-2.0</link>
      </para>
      <para>Unless required by applicable law or agreed to in writing, software distributed under
        the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY
        KIND, either express or implied. See the License for the specific language governing
        permissions and limitations under the License.</para>
      <para>Portions of this content are derivative works from content produced by Cognitive Medical
        Systems, Inc. licensed under the Apache License, Version 2.0.</para>
      <para>Additional portions of this content are derivative works from content contributed by
        Motive Medical Intelligence Inc., under Creative Commons Attribution-ShareAlike 4.0.</para>
      <para>Contributions from 2013-2018 were performed either by US Government employees, or under
        US Veterans Health Administration contracts.</para>
      <para>US Veterans Health Administration contributions by government employees are work of the
        U.S. Government and are not subject to copyright protection in the United States. Portions
        contributed by government employees are USGovWork (17USC §105). Not subject to
        copyright.</para>
      <para>See: <link xlink:href="https://www.usa.gov/government-works"
          >https://www.usa.gov/government-works</link>
      </para>
      <para>Contribution by contractors to the US Veterans Health Administration during this period
        are contractually contributed under the Apache License, Version 2.0 and US Government
        sponsorship is acknowledged under Contract VA118-16-D-1008, Task Order
        VA11817F10080007.</para>
    </legalnotice>
    <copyright>
      <year>2018</year>
      <holder>Cognitive Medical Systems, Inc.</holder>
    </copyright>
    <legalnotice>
      <title>Cognitive Medical Systems, Inc.</title>
      <para>Licensed under the Apache License, Version 2.0 (the "License"); you may not use this
        file except in compliance with the License.</para>
      <para>You may obtain a copy of the License at <link
          xlink:href="http://www.apache.org/licenses/LICENSE-2.0"
          >http://www.apache.org/licenses/LICENSE-2.0</link>
      </para>
      <para>Unless required by applicable law or agreed to in writing, software distributed under
        the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY
        KIND, either express or implied. See the License for the specific language governing
        permissions and limitations under the License.</para>
      <para>This and related content produced by Cognitive Medical Systems, Inc. licensed under the
        Apache License, Version 2.0 is available at: <link
          xlink:href="https://bitbucket.org/cogmedsys/hl7-kas-examples"
          >https://bitbucket.org/cogmedsys/hl7-kas-examples</link>
      </para>
      <para>Additional portions of this content are derivative works from content contributed by
        Motive Medical Intelligence Inc., under Creative Commons Attribution-ShareAlike 4.0. <link
          xlink:href="https://bitbucket.org/cogmedsys/kas-source-material"
          >https://bitbucket.org/cogmedsys/kas-source-material</link>
      </para>
      <para>Contributions from 2013-2018 were performed either by US Government employees, or under
        US Veterans Health Administration contracts.</para>
      <para>US Veterans Health Administration contributions by government employees are work of the
        U.S. Government and are not subject to copyright protection in the United States. Portions
        contributed by government employees are USGovWork (17USC §105). Not subject to copyright.
        See: <link xlink:href="https://www.usa.gov/government-works"
          >https://www.usa.gov/government-works</link>
      </para>
      <para>Contribution by contractors to the US Veterans Health Administration during this period
        are contractually contributed under the Apache License, Version 2.0 and US Government
        sponsorship is acknowledged under Contract VA118-16-D-1008-0007.</para>
    </legalnotice>
    <authorgroup>
      <author>
        <personname>Department of Veterans Affairs (VA)</personname>
      </author>
      <author>
        <orgname><inlinemediaobject>
            <alt>Department of Veterans Affairs Logo</alt>
            <imageobject>
              <imagedata
                fileref="file:/G:/My%20Drive/VA%20KNART%20External/Working/vacds-knart-authoring/Womens%20Health/O22SADT%20-%20Cervical%20Cancer%20Screening/clinical-white-paper-draft/images/VASealColor.jpg"
              />
            </imageobject>
          </inlinemediaobject></orgname>
      </author>
      <author>
        <orgname>Knowledge Based Systems (KBS)</orgname>
      </author>
      <author>
        <orgname>Office of Informatics and Information Governance (OIIG)</orgname>
      </author>
      <author>
        <orgname>Clinical Decision Support (CDS)</orgname>
      </author>
    </authorgroup>
    <abstract>
      <info>
        <title>Contract: VA118-16-D-1008, Task Order (TO): VA-118-16-F-1008-0007</title>
      </info>
      <para>
        <table colsep="1" frame="all" rowsep="1">
          <title>Relevant KNART Information</title>
          <tgroup align="left" cols="2">
            <thead>
              <row valign="bottom">
                <entry valign="middle">Women's Health KNART</entry>
                <entry valign="middle">Associated CLIN</entry>
              </row>
            </thead>
            <tbody>
              <row>
                <entry>Cervical Cancer Screening - Event Condition Action (ECA) Rule</entry>
                <entry>CLIN0007BA</entry>
              </row>
              <row>
                <entry>Cervical Cancer Screening - Order Set</entry>
                <entry>CLIN0008AA</entry>
              </row>
              <row>
                <entry>Cervical Cancer Screening - Documentation Template</entry>
                <entry>CLIN0008CA</entry>
              </row>
            </tbody>
          </tgroup>
        </table>
      </para>
    </abstract>
    <pubdate>June 2018</pubdate>
    <volumenum>Version 1.0</volumenum>
  </info>
  <preface>
    <title>VA Subject Matter Expert (SME) Panel</title>
    <informaltable>
      <tgroup cols="3">
        <colspec align="left"/>
        <colspec align="left"/>
        <colspec align="left"/>
        <thead>
          <row>
            <entry> Name</entry>
            <entry> Title</entry>
            <entry> Project Role</entry>
          </row>
        </thead>
        <tbody>
          <row>
            <entry>C. Yvette Williams-Harris, MD, MPH</entry>
            <entry>Physician, 1670 Clairmont Rd Atlanta, GA 30033</entry>
            <entry>SME, Primary</entry>
          </row>
          <row>
            <entry>Megan Gerber, MD, MPH</entry>
            <entry>Physician, VA Boston Healthcare System, 150 South Huntington Ave Boston, MA 02130</entry>
            <entry>SME, Secondary</entry>
          </row>
          <row>
            <entry>Caitlin M. Cusack, MD, MPH</entry>
            <entry>Contractor- Physician Informaticist, Office of Women's Health Services, 8455
              Colesville Rd, 12th Floor Silver Spring, MD 20910</entry>
            <entry>SME</entry>
          </row>
        </tbody>
      </tgroup>
    </informaltable>
  </preface>
  <preface>
    <title>Introduction</title>
    <para>The <glossterm>VA</glossterm> is committed to improving the ability of clinicians to provide
      care for patients while increasing quality, safety, and efficiency. Recognizing the importance
      of standardizing clinical knowledge in support of this goal, VA is implementing the HL7
      Knowledge Artifact Specification for a wide range of VA clinical use cases. Knowledge
      Artifacts, referred to as <glossterm>KNARTs</glossterm>, enable the structuring and encoding of
      clinical knowledge so the knowledge can be integrated with electronic health records to enable
      clinical decision support. </para>
    <para>The purpose of this Clinical Content White Paper (<glossterm>CCWP</glossterm>) is to capture
      the clinical context and intent of KNART use cases in sufficient detail to provide the
        <glossterm>KNART</glossterm> authoring team with the clinical source material to construct the
      corresponding knowledge artifacts using the <glossterm>HL7</glossterm> Knowledge Artifact
      Specification. This paper has been developed using material from a variety of sources: VA
      artifacts, clinical practice guidelines, evidence in the body of medical literature, and
      clinical expertise. After reviewing these sources, the material has been synthesized and
      harmonized under the guidance of VA subject matter experts to reflect clinical intent for this
      use case. </para>
    <para>Unless otherwise noted, items within this white paper (e.g., documentation template
      fields, orderable items, etc.) are chosen to reflect the clinical intent at the time of
      creation. To provide an exhaustive list of all possible items and their variations is beyond
      the scope of this work. </para>
  </preface>
  <preface>
      <title>Conventions Used</title>
    
    <para>Conventions used within the knowledge artifact descriptions include: <itemizedlist
        mark="none" spacing="compact">
        <listitem>
          <para>&lt;obtain&gt; : Indicates a prompt to obtain the information listed <itemizedlist
              mark="bullet" spacing="compact">
              <listitem>
                <para>If possible, the requested information should be obtained from the underlying
                  system(s). Otherwise, prompting the user for information may be required</para>
              </listitem>
              <listitem>
                <para>Default Values: Unless otherwise noted, &lt;obtain&gt; indicates to obtain the
                  most recent observation. It is recognized that this default time-frame value may
                  be altered by future implementations</para>
              </listitem>
            </itemizedlist></para>
        </listitem>

        <listitem>
          <para>[...]: Square brackets enclose explanatory text that indicates some action on the
            part of the clinical user, or general guidance to the clinical or technical teams.
            Examples include, but are not limited to:</para>

          <itemizedlist mark="none" spacing="normal">
            <listitem>
              <para>[Begin ...], [End ...]: Indicates the start and end of specific areas to clearly
                delineate them for technical purposes.</para>

              <para>[Activate ...]: Initiates another knowledge artifact or knowledge artifact
                section.</para>

              <para>[Section Prompt: ...]: If this section is applicable, then the following prompt
                should be displayed to the user.</para>

              <para>[Section Behavior: ...]: Indicates technical constraints or considerations for
                the selection of items outlined in the section prompt.</para>

              <para>[Attach: ...]: Indicates that the specified item (e.g. procedure or result
                interpretation) should be attached to the documentation template if
                available.</para>

              <para>[Link: ...]: Indicates that rather than attaching an item (e.g. image), a link
                should be included in the documentation template.</para>

              <para>[Clinical Comment: ...]: Indicates technical considerations or notes to be
                utilized for KNART authoring and at time of implementation planning.</para>

              <para>[Technical Note: ...]: Indicates technical considerations or notes to be
                utilized for KNART authoring and at time of implementation planning.</para>

              <para>[If ...]: Indicates the beginning of a conditional section.</para>

              <para>[Else, ...]: Indicates the beginning of the alternative branch of a conditional
                section.</para>

              <para>[End if ...]: Indicates the end of a conditional section.</para>
            </listitem>
          </itemizedlist>
        </listitem>

        <listitem>
          <para>☐ [Check box]: Indicates items that should be selected based upon the section
            selection behavior.</para>
        </listitem>
      </itemizedlist></para>

  </preface>
  <chapter>
    <title>Women's Health: Cervical Cancer Screening</title>
    <para>[Begin Women’s Health: Cervical Cancer Screening.]</para>
    <section>
      <title>Clinical Context</title>
      <para>[Begin Clinical Context.]</para>
      <para>Cervical cancer is largely a preventable disease due to the success of early treatment
        enabled by appropriate preventive screening (ACOG 2016). Therefore, it is imperative that
        women be screened according to evidence-based guidelines. Screening is particularly
        important, as secular trends indicate decreasing levels of screening among women and the
        persistence of health care disparities among certain groups of women based on race,
        ethnicity, and socioeconomic factors.</para>
      <para>The Cervical Cancer Screening KNART set is intended to prompt providers to identify a
        woman's cervical cancer risk category; counsel her about that risk; identify her screening
        preferences; screen based on age, risk, and patient preference; and document the entire
        process.</para>
      <table>
        <title>Clinical Context Domains</title>
        <tgroup cols="2">
          <tbody>
            <row>
              <entry>Target User</entry>
              <entry>Provider to include Primary Care and Gynecologists</entry>
            </row>
            <row>
              <entry>Patient</entry>
              <entry>Female that is at least 21 years of age or older</entry>
            </row>
            <row>
              <entry>Priority</entry>
              <entry>Routine</entry>
            </row>
            <row>
              <entry>Specialty</entry>
              <entry>Primary Care and Gynecology</entry>
            </row>
            <row>
              <entry>Location</entry>
              <entry>Outpatient</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para>[End Clinical Context.]</para>
    </section>
    <section>
      <title>Knowledge Artifacts</title>
      <para>[Begin Knowledge Artifacts.]</para>
      <para>This section describes the Clinical Decision Support (CDS) knowledge artifacts specific
        to cervical cancer screening. These knowledge artifacts are intended for users providing
        primary and preventative care to women to ensure that timely cervical cancer screening is
        performed and that women’s preferences are incorporated into the decision-making process.
        Target clinical users include primary care providers, women's health clinical providers and
        gynecologists. The patient cohort includes women aged 21 years and older with an intact
        cervix and without cervical cancer risk factors.</para>
      <para>Women with the following risk factors are excluded from the patient cohort as they are
        followed in accordance with alternative protocols:</para>
      <itemizedlist>
        <listitem>
          <para> Women who have an immune disorder such as being Human Immunodeficiency Virus
              (<glossterm>HIV</glossterm>) positive. </para>
        </listitem>
        <listitem>
          <para> Women with a history of high-grade precancerous cervical lesion(s) or cervical
            cancer. </para>
        </listitem>
        <listitem>
          <para> Women with in utero exposure to diethylstilbestrol. </para>
        </listitem>
      </itemizedlist>
      <para>This section describes the CDS knowledge artifacts that are part of the Cervical Cancer
        Screening group, and include:</para>
      <itemizedlist>
        <listitem>
          <para> An Event-Condition-Action (<glossterm>ECA</glossterm>) Rule: Cervical Cancer
            Screening </para>
          <itemizedlist>
            <listitem>
              <para>Rule logic that describes the activation of the documentation template and order
                set.</para>
            </listitem>
            <listitem>
              <para>Actions may include activating documentation templates or order sets.</para>
            </listitem>
          </itemizedlist>
        </listitem>
        <listitem>
          <para> A Documentation Template: Cervical Cancer Screening </para>
          <itemizedlist>
            <listitem>
              <para>A template that facilitates documentation of the management of a patient’s
                cervical cancer screening.</para>
            </listitem>
            <listitem>
              <para>Includes logic for the appropriate display of the documentation sections.</para>
            </listitem>
          </itemizedlist>
        </listitem>
        <listitem>
          <para> An Order Set: Cervical Cancer Screening </para>
          <itemizedlist>
            <listitem>
              <para>Orderable items associated with management of cervical cancer screening.</para>
            </listitem>
            <listitem>
              <para>Includes logic for the appropriate display of the order set.</para>
            </listitem>
          </itemizedlist>
        </listitem>
      </itemizedlist>
      <para>[End Knowledge Artifacts.]</para>
      <para>[End Women’s Health: Cervical Cancer Screening.]</para>
    </section>
  </chapter>
  <chapter>
    <title>Event-Condition-Action (<glossterm>ECA</glossterm>) Rule: Women's Health: Cervical Cancer
      Screening</title>
    <para>[Begin ECA Rule.]</para>
    <section>
      <title>Knowledge Narrative</title>
      <para>[Begin Knowledge Narrative.]</para>
      <para>[See Clinical Context in Chapter 1.]</para>
      <para>The Event-Condition-Action Rule will assure:</para>
      <itemizedlist>
        <listitem>
          <para> Clinicians have access to the current guidelines at the point of care to guide
            their counseling; and </para>
        </listitem>
        <listitem>
          <para> Patients are notified when they are due for cervical cancer screening either during
            or outside of in-person clinical visits. </para>
        </listitem>
      </itemizedlist>
      <para>[Clinical Comment: The purpose of the <glossterm>ECA</glossterm> rule for cervical
        cancer screening is to assess the patient’s cervical cancer screening status and if
        warranted, to document cervical cancer risk and screening desires as well as to order the
        recommended test/screen.</para>
      <para>[End Knowledge Narrative.]</para>
    </section>
    <section>
      <title>Primary Level (trunk) cohort identification</title>
      <para>[Begin Primary Level (trunk) cohort identification.]</para>
      <bridgehead>Event</bridgehead>
      <para>[Begin Event]</para>
      <itemizedlist>
        <listitem>
          <para>Opening of the patient record during an outpatient visit to primary care provider or gynecologist</para>
          <para>OR</para>
        </listitem>
        <listitem>
          <para>System run of preventive screening rules, run monthly.</para>
        </listitem>
      </itemizedlist>
      <para>[End Event]</para>
      
        <bridgehead renderas="sect4">Conditions</bridgehead>
        <para>[Begin Conditions]</para>
        <itemizedlist>
          <listitem>
            <para>Include female patients aged 21 years or older. </para>
          </listitem>
          <listitem>
            <para>Exclude women who have had a total hysterectomy (cervix + uterus), women who have
              congenital absence of the cervix, and women who meet any of the following high-risk
              criteria:</para>
            <itemizedlist>
              <listitem>
                <para> Immunosuppression; or</para>
              </listitem>
              <listitem>
                <para> Presence of <glossterm>HIV</glossterm> infection; or</para>
              </listitem>
              <listitem>
                <para> Exposure to diethylstilbestrol in utero; or</para>
              </listitem>
              <listitem>
                <para> A history of high-grade dysplasia or prior treatment for Cervical
                Intra-epithelial Neoplasia (<glossterm>CIN</glossterm>) 2,
                  CIN 3, or cervical cancer; or</para>
              </listitem>
              <listitem>
              <para> Women in whom screening has been discontinued due to:</para>
              <itemizedlist>
                <listitem>
                  <para>life expectancy less than 10 years</para>
                </listitem>
                <listitem>
                  <para>history of adequate screening among women over 65</para>
                </listitem>
              </itemizedlist>
            </listitem>
            </itemizedlist>
          </listitem>
        </itemizedlist>
      <para>[Technical Note: Adequate negative prior screening results are defined as 3 consecutive negative cytology results or 2 consecutive negative co-test results within the previous 10 years, with the most recent test performed within the past 5 years.]</para>
        <para>[End Conditions]</para>
      <bridgehead renderas="sect4">Actions</bridgehead>
        <para>[Begin Actions]</para>
        <itemizedlist spacing="compact">
          <listitem>
          <para>Activate Chapter 2, sections 2.2.1- 2.2.6</para>
        </listitem>
        </itemizedlist>
        <para>[End Actions]</para>
      <para>[End Primary Level (trunk) cohort identification.]</para>
      
      <section>
        <title>Cervical Cancer Screening for 21-29 Years of Age: In Person</title>
        <para>[Begin Cervical Cancer Screening for 21-29 years of age: In Person.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Opening of the patient record during an outpatient visit to primary care
                provider or gynecologist.</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>

        <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist spacing="compact">
            <listitem>
            <para>Patient age is ≥ 21 to &lt; 30 years old</para>
          </listitem>
          <listitem>
            <para>No cervical cytology exam within the past 3 years or patient coming due in the
              next 60 days.</para>
          </listitem>
          </itemizedlist>
        <para>[Technical Note: If Due Date > Today + 60 Days, stop.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Open the Cervical Cancer Screening Documentation Template</para>
            </listitem>
            <listitem>
              <para>Open the Cervical Cancer Screening Order Set</para>
            </listitem>
          </itemizedlist>
        <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the provider.]</para>
          <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for 21-29 years of age: In Person .]</para>
        </section>
      <section>
        <title>Cervical Cancer Screening for 21-29 Years of Age: Reporting</title>
        <para>[Begin Cervical Cancer Screening for 21-29 years of age: Reporting.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Monthly system run of preventative screening rules</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>
                  <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist spacing="compact">
            <listitem>
            <para>Patient is ≥ 21 to &lt; 30 years old</para>
          </listitem>
          <listitem>
            <para>Has had no cervical cytology exam within the past 3 years</para>
          </listitem>
          </itemizedlist>
        <itemizedlist>
          <listitem>
            <para>Due Date is within 30 days in the past and 60 days in the future of the system run
              date</para>
          </listitem>
        </itemizedlist>
        <para>[Technical Note: Given a monthly system run, this condition results in 3 notifications
          being sent to the patient.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Send patient cervical cancer screening <quote>due</quote> notification</para>
            </listitem>
          </itemizedlist>
        <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the care team.]</para>
          <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for 21-29 years of age: Reporting.]</para>
        </section>

      <section>
        <title>Cervical Cancer Screening for 30 to 65 Years of Age: In Person</title>
        <para>[Begin Cervical Cancer Screening for 30-65 Years of Age: In Person.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Opening of the patient record during an outpatient visit to primary care
                provider or gynecologist.</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>
                  <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist>
            <listitem>
            <para>Patient age is ≥ 30 and ≤ 65 years old</para>
          </listitem>
          <listitem>
            <para>Has had none of the following screens:</para>
            <itemizedlist>
              <listitem>
                <para>Cervical Cytology within the past 3 years, or</para>
              </listitem>
              <listitem>
                <para>Cotesting (cervical cytology and Human Papillomavirus
                    (<glossterm>HPV</glossterm>) screen) within the past 5 years, or</para>
              </listitem>
              <listitem>
                <para>HPV screen alone within the past 5 years.</para>
              </listitem>
            </itemizedlist>
          </listitem>
          </itemizedlist>
        <para>[Technical Note: If Due Date > Today + 60 Days, stop.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Open Cervical Cancer Screening Documentation Template.</para>
            </listitem>
            <listitem>
              <para>Open Cervical Cancer Screening Order Set</para>
            </listitem>
          </itemizedlist>
        <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the provider.] </para>
          <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for 30-65 Years of Age: In Person.]</para>
        </section>

      <section>
        <title>Cervical Cancer Screening for 30 to 65 Years of Age: Reporting</title>
        <para>[Begin Cervical Cancer Screening for 30-65 Years of Age: Reporting.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Monthly system run of preventative screening rules</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>
                  <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist>
          <listitem>
            <para>Patient age is ≥ 30 and ≤ 65 years old</para>
          </listitem>
          <listitem>
            <para>Has had none of the following screens:</para>
            <itemizedlist>
              <listitem>
                <para>Cervical Cytology within the past 3 years, or</para>
              </listitem>
              <listitem>
                <para>Cotesting (cervical cytology and (<glossterm>HPV</glossterm>) screen) within the past 5 years, or</para>
              </listitem>
              <listitem>
                <para>HPV screen alone within the past 5 years.</para>
              </listitem>
            </itemizedlist>
          </listitem>
          </itemizedlist>
        <para>Due Date is within 30 days in the past and 60 days in the future of the system run
          date.</para>
        <para>[Technical Note: Given a monthly system run, this condition results in 3 notifications
          being sent to the patient.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Send patient cervical cancer screening <quote>due</quote> notification</para>
            </listitem>
          </itemizedlist>
          <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the care team.]</para>
        <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for 30-65 Years of Age: Reporting.]</para>
        </section>

      <section>
        <title>Cervical Cancer Screening for Older than 65 Years of Age: In Person</title>
        <para>[Begin Cervical Cancer Screening for Older than 65 Years of Age: In Person.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Opening of the patient record during an outpatient visit to primary care
                provider or gynecologist.</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>
                  <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist>
          <listitem>
            <para>Patient age > 65 years old</para>
          </listitem>
          <listitem>
            <para>Without adequate negative prior screening.  Those adequately screened are those with: </para>
            <itemizedlist>
              <listitem>
                <para>Three consecutive negative cervical Cytology results within the past 10 years, or</para>
              </listitem>
              <listitem>
                <para>Two consecutive negative co-test (cervical cytology and (<glossterm>HPV</glossterm>) screen) results within the past 5 years, or</para>
              </listitem>
              <listitem>
                <para>Two negative consecutive HPV screens alone within the past 5 years.</para>
              </listitem>
            </itemizedlist>
          </listitem>
        </itemizedlist>
        <para>[Technical Note: If Due Date > Today + 60 Days, stop.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Open Cervical Cancer Screening Documentation Template</para>
            </listitem>
            <listitem>
              <para>Open Cervical Cancer Screening Order Set</para>
            </listitem>
          </itemizedlist>
 
          <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the provider.]</para>

          <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for Older than 65 Years of Age: In Person.]</para>
        </section>

      <section>
        <title>Cervical Cancer Screening for Older than 65 Years of Age: Reporting</title>
        <para>[Begin Cervical Cancer Screening for Older than 65 Years of Age: Reporting.]</para>
        <bridgehead renderas="sect4">Event</bridgehead>
          <para>[Begin Event]</para>
          <itemizedlist spacing="compact">
            <listitem>
              <para>Monthly system run of preventative screening rules</para>
            </listitem>
          </itemizedlist>
          <para>[End Event]</para>
                  <bridgehead renderas="sect4">Conditions</bridgehead>
          <para>[Begin Conditions]</para>
          <itemizedlist>
          <listitem>
            <para>Patient age > 65 years old</para>
          </listitem>
          <listitem>
            <para>Without adequate negative prior screening.  Those adequately screened are those with:</para>
            <itemizedlist>
              <listitem>
                <para>Three consecutive negative cervical Cytology results within the past 10 years, or</para>
              </listitem>
              <listitem>
                <para>Two consecutive negative co-test (cervical cytology and(<glossterm>HPV</glossterm>) screen) within the past 5 years, or</para>
              </listitem>
              <listitem>
                <para>Two negative consecutive HPV screens alone within the past 5 years.</para>
              </listitem>
            </itemizedlist>
          </listitem>
        </itemizedlist>
        <itemizedlist>
          <listitem>
            <para>Due Date is within 30 days in the past and 60 days in the future of the system run
              date</para>
          </listitem>
        </itemizedlist>
        <para>[Technical Note: Given a monthly system run, this condition results in 3 notifications
          being sent to the patient.]</para>
          <para>[End Conditions]</para>
                  <bridgehead renderas="sect4">Actions</bridgehead>
          <para>[Begin Actions]</para>
          <itemizedlist>
            <listitem>
              <para>Send patient cervical cancer screening <quote>due</quote> notification</para>
            </listitem>
          </itemizedlist>
        <para>[Technical Note: Make sure the associated recommendations and guidelines for the age
          group are available to the care team.] </para>
        
          <para>[End Actions]</para>
          <para>[End Cervical Cancer Screening for Older than 65 Years of Age: Reporting.]</para>
        <para>[End ECA Rule.]</para>
        </section>
    </section>

  </chapter>
  <chapter>
    <title>Documentation Template: Women's Health: Cervical Cancer Screening</title>
    <para>[Begin Documentation Template.]</para>
    <para>[Technical Note: This documentation template should be made available for patients for
      whom Cervical Cancer Screening <glossterm>ECA</glossterm> Rule KNART is activated (i.e.,
      criteria met).]</para>
    <section>
      <title>Knowledge Narrative</title>
      <para>[Begin Knowledge Narrative.]</para>
      <para>[See Clinical Context in Chapter 1.]</para>
      <para>[Clinical Comment: The Cervical Cancer Screening Documentation Template will guide
        clinicians in their conversations with a woman based upon her age and risk-based screening
        preferences as well as allow for the efficient documentation of those conversations and
        capture the woman's personal preferences.]</para>
      <para>[Technical Note: Discrete data elements will be acquired through a series of questions
        and answers. Any information that can be obtained from the system should pre-populate the
        field in a manner that is apparent to the user.]</para>
      <para>[Technical Note: The template should automatically adjust to be specific to the
        following age groups: 21-29, 30-65 and older than 65 years of age.]</para>
      <para>[Technical Note: The template should allow for the documentation of prior cervical
        cancer screening and results from outside of the organization.]</para>
      <para>[End Knowledge Narrative.]</para>
    </section>
    <section>
      <title>History</title>
      <para>[Begin History section.]</para>
      <para>[Section Prompt: Patient Age.]</para>
      <blockquote>
        <para>&lt;obtain&gt; Age in years</para>
      </blockquote>
      <para>[Section Prompt: History of high-grade dysplasia or prior treatment for Cervical
        Intraepithelial Neoplasia (<glossterm>CIN</glossterm>) 2 or higher?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Previously treated for <glossterm>CIN</glossterm> 2, <glossterm>CIN</glossterm> 3, or
        Cervical Cancer?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Section Prompt: Exposed to Diethylstilbestrol in Utero?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Section Prompt: Hysterectomy with Removal of Cervix (Total Hysterectomy)?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Section Prompt: Infected with <glossterm>HIV</glossterm>?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Section Prompt: Immunocompromised (Other Than <glossterm>HIV</glossterm>)?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[Section Prompt: Significant Comorbidity Limits Life Span to &lt; 10 Years?]</para>
      <para>[Section Selection Behavior: Select one. Required.]</para>
      <blockquote>
        <para>☐ Yes <blockquote>
            <para>&lt;obtain> Details</para>
          </blockquote></para>
        <para>☐ No</para>
      </blockquote>
      <para>[End History section.]</para>
    </section>
    <section>
      <title>Laboratory Studies</title>
      <para>[Begin Laboratory Studies section.]</para>
      <section>
        <title>Laboratory Studies: Aged 21–29 Years.</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for 21-29 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Most Recent Cervical Cytology.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
      </section>
      <section>
        <title>Laboratory Studies: Aged 30–65 Years</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for 30 to 65 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Most Recent Cervical Cytology.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[Section Prompt: Most Recent <glossterm>HPV</glossterm> Screening.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
      </section>
      <section>
        <title>Laboratory Studies: Aged Older Than 65 Years</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for Older than 65 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Most Recent Cervical Cytology.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[Section Prompt: Second-Most Recent Cervical Cytology.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[Section Prompt: Third-Most Recent Cervical Cytology.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[Section Prompt: Most Recent <glossterm>HPV</glossterm> Screen.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[Section Prompt: Second-Most Recent <glossterm>HPV</glossterm> Screen.]</para>
        <blockquote>
          <para> &lt;obtain> Results</para>
          <para> &lt;obtain> Date</para>
        </blockquote>
        <para>[End Laboratory Studies section.]</para>
      </section>
    </section>
    <section>
      <title>Plan of Care</title>
      <para>[Begin Plan of Care.]</para>
      <para>[Section Prompt: Due Date for Cervical Cancer Screening.]</para>
      <blockquote>
        <para>&lt;obtain> Due Date</para>
        <para>[Technical Note: Due Date is calculated per patient-relevant ECA rule.]</para>
      </blockquote>
      <section>
        <title>Plan: Aged 21–29 Years</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for 21-29 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Cervical Cancer Preventive Screening Plan.]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Continue Screening Every Three Years with Cervical Cytology Alone</para>
          <para>☐ Discontinue Screening Due to Life Expectancy &lt; 10 Years</para>
          <para>☐ Other <blockquote>
              <para> &lt;obtain> Details</para>
            </blockquote></para>
        </blockquote>
        <para>[Section Prompt: Plan Discussed with and Agreed to by Patient?]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Yes</para>
          <para>☐ No<blockquote>
              <para> &lt;obtain> Explanation </para>
            </blockquote></para>
        </blockquote>
      </section>
      <section>
        <title>Plan: Aged 30–65 Years</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for 30 to 65 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Cervical Cancer Preventive Screening Plan.]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Continue Screening Every Three Years with Cervical Cytology Alone</para>
          <para>☐ Continue Screening Every Five Years with Cotesting (Cervical Cytology Plus
            <glossterm>HPV</glossterm> Screening) </para>
          <para>☐ Continue Screening every 5 Years with HPV screening alone</para>
          <para>☐ Discontinue Screening Due to Life Expectancy &lt; 10 Years</para>
          <para>☐ Other <blockquote>
              <para>&lt;obtain> Details</para>
            </blockquote></para>
        </blockquote>
        <para>[Section Prompt: Plan Discussed with and Agreed to by Patient?]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Yes</para>
          <para>☐ No<blockquote>
              <para>&lt;obtain> Explanation</para>
            </blockquote></para>
        </blockquote>
      </section>
      <section>
        <title>Plan: Aged Older Than 65 Years</title>
        <para>[This section of the documentation template should be made available when the ECA Rule
          Cervical Cancer Screening for Older than 65 Years of Age: In Person is executed.]</para>
        <para>[Section Prompt: Cervical Cancer Screening Plan.]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Continue Screening Every Three Years with Cervical Cytology Alone</para>
          <para>☐ Continue Screening Every Five Years with Cotesting (Cervical Cytology Plus
            <glossterm>HPV</glossterm> Screening) </para>
          <para>☐ Continue Screening every 5 Years with HPV Screening alone</para>
          <para>☐ Discontinue Screening Due to Life Expectancy &lt; 10 Years</para>
          <para>☐ Discontinue Screening because adequate screening has been completed (Three
            Consecutive Negative Cytology Results within the Last 10 Years OR Two Consecutive
            Negative Cotesting Results within the Last 10 Years, with the Most Recent Screening of
            either type Performed within the Past 5 Years) </para>
          <para>☐ Other <blockquote>
              <para>&lt;obtain> Details</para>
            </blockquote></para>
        </blockquote>
        <para>[Section Prompt: Plan Discussed with and Agreed to by Patient?]</para>
        <para>[Section Selection Behavior: Select one. Required.]</para>
        <blockquote>
          <para>☐ Yes</para>
          <para>☐ No<blockquote>
              <para>&lt;obtain> Explanation</para>
            </blockquote></para>
        </blockquote>
        <para>[End Plan of Care.]</para>
        <para>[End Documentation Template.]</para>
      </section>
    </section>
  </chapter>
  <chapter>
    <title>Order Set: Women's Health: Cervical Cancer Screening</title>
    <para>[Begin Order Set.]</para>
    <para>[Technical Note: This Order Set is to be made available for patients for whom Cervical
      Cancer Screening <glossterm>ECA</glossterm> Rule KNART was positive.]</para>
    <section>
      <title>Knowledge Narrative</title>
      <para>[Begin Knowledge Narrative.]</para>
      <para>[See Clinical Context in Chapter 1.]</para>
      <para>[Clinical Comment: The order set allows users to order cervical cancer screening,
        including cervical cytology and <glossterm>HPV</glossterm> co-testing, quickly and
        efficiently.]</para>
      <para>[Technical Note: Currently, VA users can enter orders directly or they can order from
        within the clinical reminder dialog (see Appendix A).]</para>
      <para>[End Knowledge Narrative.]</para>
    </section>
    <section>
      <title>Cervical Cancer Screening</title>
      <para>[Begin Cervical Cancer Screening.]</para>
      <para>[Section Prompt: Laboratory Studies.]</para>
      <para>[Section Selection Behavior: Select one or more. Optional.]</para>
      <blockquote>
        <para>☐ Papanicolaou test cervical cells for cervical cancer screening routine</para>
        <para>☐ Liquid-based cytology cervical cells for cervical cancer screening routine with reflex HPV testing if Age >= 30</para>
        <para>☐ <glossterm>HPV</glossterm> screen as part of cervical cancer co-testing routine</para>
        <para>☐ HPV screen alone for cervical cancer screening routine </para>
      </blockquote>
      <para>[Section Prompt: Patient and Caregiver Education.]</para>
      <para>[Selection Behavior: Select one. Optional.]</para>
      <blockquote>
        <para>☐ Cervical cancer screening education (Pap smear testing, liquid-based cervical
          cytology, <glossterm>HPV</glossterm> testing, and cervical cancer) routine</para>
      </blockquote>
      <para>[End Cervical Cancer Screening.]</para>
      <para>[End Order Set.]</para>
    </section>
  </chapter>
  <bibliography>
    <info>
      <title>Bibliography/Evidence</title>
    </info>
    <biblioentry>
      <author>
        <orgname>Committee on Practice Bulletins—Gynecology.</orgname>
      </author>
      <citetitle pubwork="webpage">Practice Bulletin No. 168: Cervical Cancer Screening and
        Prevention</citetitle>
      <citetitle pubwork="journal">Obstet Gynecol</citetitle>
      <pubdate>2016</pubdate>
      <volumenum>128</volumenum>
      <issuenum>(4)</issuenum>
      <pagenums>e111-e130</pagenums>
    </biblioentry>
    <biblioentry>
      <author>
        <orgname>Health Promotion and Disease Prevention.</orgname>
      </author>
      <citetitle pubwork="webpage">Provider Fact Sheet: Cervical Cancer Screening. National Center
        for Health Promotion and Disease Prevention website</citetitle>
      <bibliomisc>https://www.prevention.va.gov/docs/CervicalCProvider.pdf.</bibliomisc>
      <pubdate>June 2013</pubdate>
    </biblioentry>
    <biblioentry>
      <citetitle pubwork="webpage">Cervical Cancer Screening Guidelines for Average Risk
        Women</citetitle>
      <bibliomisc>https://www.cdc.gov/cancer/cervical/pdf/guidelines.pdf</bibliomisc>
      <pubdate>July 2017</pubdate>
    </biblioentry>
    <biblioentry>
      <author>
        <orgname>Committee on Gynecologic Practice</orgname>
      </author>
      <citetitle pubwork="webpage">Committee Opinion No. 534: Well-Woman Visit. Obstetrics and
        Gynecology</citetitle>
      <pubdate>August 2012</pubdate>
      <volumenum>120</volumenum>
      <issuenum>(2 Pt 1)</issuenum>
      <pagenums>421</pagenums>
    </biblioentry>
    <biblioentry>
      <citetitle pubwork="webpage">Department of Veteran Affairs National Center for Health
        Promotion and Disease Prevention, Cervical Cancer Screening</citetitle>
      <bibliomisc>https://www.prevention.va.gov/Preventing_Diseases/Screening_for_Cervical_Cancer.asp#frequency</bibliomisc>
      <pubdate>July 2017</pubdate>
    </biblioentry>
    <biblioentry>
      <abbrev>Massad, 2013</abbrev>
      <authorgroup>
        <author>
          <personname><surname>Massad</surname><firstname>LS</firstname></personname>
        </author>
        <author>
          <personname><surname>Einstein</surname><firstname>MH</firstname></personname>
        </author>
        <author>
          <personname><surname>Huh</surname><firstname>WK</firstname></personname>
        </author>
        <author>
          <personname><surname>Katki</surname><firstname>HA</firstname></personname>
        </author>
        <author>
          <personname><surname>Kinney</surname><firstname>WK</firstname></personname>
        </author>
        <author>
          <personname><surname>Schiffman</surname><firstname>M</firstname></personname>
        </author>
        <author>
          <personname><surname>Solomon</surname><firstname>D</firstname></personname>
        </author>
        <author>
          <personname><surname>Wentzensen</surname><firstname>N</firstname></personname>
        </author>
        <author>
          <personname><surname>Lawson</surname><firstname>HW.</firstname></personname>
        </author>
      </authorgroup>
      <citetitle pubwork="article">2012 Updated Consensus Guidelines For The Management Of Abnormal
        Cervical Cancer Screening Tests And Cancer Precursors</citetitle>
      <citetitle pubwork="journal">stetrics and Gynecology</citetitle>
      <pubdate>April 1, 2013</pubdate>
      <volumenum>121</volumenum>
      <issuenum>(4)</issuenum>
      <pagenums>829-46</pagenums>
    </biblioentry>
    <biblioentry>
      <citetitle pubwork="webpage">United States Preventive Task Force (USPTF) Cervical Cancer
        Screening Guidelines</citetitle>
      <bibliomisc>https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cervical-cancer-screening</bibliomisc>
      <pubdate>August 2018</pubdate>
    </biblioentry>
  </bibliography>

  <appendix>
    <info>
      <title>Existing VA Artifacts</title>
    </info>
    <figure>
      <title>Pap Smear Screening Clinical Reminder</title>
      <mediaobject>
        <alt>VA Screenshot of Reminder Resolution: PAP Smear Screening</alt>
        <imageobject>
          <imagedata align="center" contentdepth="100%"
            fileref="images/Fig3PapSmearScreening.png"
            scalefit="1" width="100%"/>
        </imageobject>
      </mediaobject>
    </figure>
    <figure>
      <title>Pap Smear Screening Clinical Reminder with Record Outside Pap section expanded</title>
      <mediaobject>
        <alt>VA Screenshot of Reminder Resolution: PAP Smear Screening showing record prior or
          outside Pap and/or HPV results</alt>
        <imageobject>
          <imagedata align="center" contentdepth="100%"
            fileref="images/Fig4PapSmearScreeningWithRecord.png"
            scalefit="1" width="100%"/>
        </imageobject>
      </mediaobject>
    </figure>
    <figure>
      <title>HPV orders</title>
      <mediaobject>
        <alt>VA Screenshot of HPV orders</alt>
        <imageobject>
          <imagedata align="center" contentdepth="100%"
            fileref="images/Fig1HPVOrders.png"
            scalefit="1" width="100%"/>
        </imageobject>
      </mediaobject>
    </figure>
  </appendix>
  
  <glossary role="auto">
    <info>
      <title>Acronyms</title>
    </info>
  </glossary>
</book>
